Haruki Eguchi Selected Research

ethylenediamine (ethylenediamine dihydroiodide)

3/2018	Treatment of oral cancer using magnetized paclitaxel.
8/2017	The iron chelating agent, deferoxamine detoxifies Fe(Salen)-induced cytotoxicity.
1/2017	Hyperthermia and chemotherapy using Fe(Salen) nanoparticles might impact glioblastoma treatment.
1/2016	Simultaneous hyperthermia-chemotherapy with controlled drug delivery using single-drug nanoparticles.
3/2015	A magnetic anti-cancer compound for magnet-guided delivery and magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Haruki Eguchi Research Topics

Disease

11	Neoplasms (Cancer) 01/2019 - 08/2007
6	Hyperthermia 01/2019 - 05/2012
2	ST Elevation Myocardial Infarction 03/2021 - 12/2017
2	Mouth Neoplasms (Oral Cancer) 03/2018 - 05/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 02/2011
2	Tongue Neoplasms (Tongue Neoplasm) 01/2017 - 01/2016
2	Thrombosis (Thrombus) 01/2013 - 10/2012
1	Death (Near-Death Experience) 03/2021
1	Myocardial Infarction 03/2021
1	Ischemic Stroke 03/2021
1	Poisoning 08/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Melanoma (Melanoma, Malignant) 03/2015
1	Acute Coronary Syndrome 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 05/2012

Drug/Important Bio-Agent (IBA)

6	mu-oxo N,N'- bis(salicylidene)ethylenediamine ironIBA 01/2019 - 03/2015
6	Pharmaceutical PreparationsIBA 03/2018 - 01/2013
5	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 03/2018 - 03/2015
5	IronIBA 03/2018 - 03/2015
3	MetalsIBA 08/2017 - 01/2013
2	disalicylaldehyde ethylenediamine (salen)IBA 08/2017 - 03/2015
2	ferric oxide (iron oxide)IBA 01/2016 - 05/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2015 - 05/2012
1	LDL CholesterolIBA 03/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2017
1	AntidotesIBA 08/2017
1	Drug CarriersIBA 07/2017
1	GoldIBA 07/2017
1	TransferrinsIBA 07/2017
1	Carmustine (FIVB)FDA Link 01/2017
1	Saline SolutionIBA 01/2017
1	MicellesIBA 03/2015
1	ferumoxides (Feridex)FDA Link 05/2014
1	Cisplatin (Platino)FDA LinkGeneric 05/2014
1	AntioxidantsIBA 05/2012
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2012
1	omega-Chloroacetophenone (Mace)IBA 02/2011
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2007
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 08/2007
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 08/2007
1	ProdrugsIBA 08/2007

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2019 - 08/2007
3	Therapeutics 11/2018 - 05/2012
3	Stents 01/2013 - 10/2012
2	Percutaneous Coronary Intervention 03/2021 - 12/2017
2	Induced Hyperthermia (Thermotherapy) 01/2016 - 05/2014
1	Catheters 01/2019
1	Intra-Arterial Injections 01/2019
1	Chelation Therapy (Therapy, Chelation) 08/2017
1	Intravenous Administration 01/2016
1	Precision Medicine 03/2015
1	Radiotherapy 05/2014
1	Drug-Eluting Stents 01/2013